Back to search
FDAFDA · Food and drugs·Recall number Z-1806-2026

Yeastone Broth, 11ML, 10/BOX YY3462

Published April 22, 2026 · Recall initiated: March 24, 2026

Summary

FDA records medical device Class II recall Z-1806-2026, published April 22, 2026 and initiated March 24, 2026. Recalling firm: Remel, Inc; Status: Ongoing; Reported quantity: 2819; Lot: UDI-DI 848838018817 lots 321046, 329835, 330316, 327069, 330317, 336325, 338314, 341161, 303851, 311723. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Products may report incorrect AST results during quality control. Health consequences may include delayed response or the need to change to another antifungal agent if laboratory ignores Quality Control test result.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Remel, Inc
Distributor
Worldwide distribution - US Nationwide and the countries of Canada, Vietnam, France, Argentina, Qatar, New Zealand, Uruguay, Turkey, Netherlands, Singapore.
Lot
UDI-DI 848838018817 lots 321046, 329835, 330316, 327069, 330317, 336325, 338314, 341161, 303851, 311723
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Yeastone Broth, 11ML, 10/BOX YY3462 recalled?

Yes. FDA published recall Z-1806-2026 on April 22, 2026. Reported hazard: Products may report incorrect AST results during quality control. Health consequences may include delayed response or the need to change to another antifungal agent if laboratory ignores Quality Control test result.

What should I do if I have this product?

Voluntary: Firm initiated · Letter